Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
Matthew G. Cottingham(University of Oxford), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Adrian V. S. Hill(Jenner Institute), Saroj Saurya(Centre for Human Genetics), Rikke Fredslund Andersen(Centre for Human Genetics), Alexandra J. Spencer(University of Oxford), Julie Furze(University of Oxford)
Cited by 93
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661